美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Definium Therapeutics

34.44

-0.7600-2.16%

成交量：73.02万

成交额：2,529.91万

市值：46.28亿

市盈率：-9.89

高：34.95

开：34.83

低：34.03

收：35.20

52周最高：49.70

52周最低：10.46

股本：1.34亿

流通股本：1.30亿

量比：0.53

换手率：0.56%

股息：- -

股息率：- -

每股收益(TTM):-3.4823

每股收益(LYR):-2.0600

净资产收益率：-64.09%

总资产收益率：-20.64%

市净率：5.04

市盈率(LYR):-16.72

数据加载中...

总览公司新闻资讯公告

BUZZ-Definium Therapeutics宣布5亿美元股权融资后股价下跌

BUZZ——美国股市动态-维斯通、英赛特、阿波吉

BUZZ-Definium Therapeutics股价大涨，因其抗抑郁药物晚期临床试验数据表现良好

Definium Therapeutics股价盘前飙升18.5%，其基于LSD的抑郁药物在后期试验中显效

Definium公司基于LSD的药片在晚期临床试验中减轻了抑郁症状

Definium Therapeutics公布DT120口崩片治疗重度抑郁症的3期EMERGE研究积极顶线结果

Definium Therapeutics：DT120口崩片研究达成主要及所有关键次要疗效终点

Definium Therapeutics 公布 DT120 ODT 临床数据：总体耐受性良好，未出现严重不良事件或自杀倾向信号

Definium Therapeutics将于2026年6月22日讨论重度抑郁症III期EMERGE研究的顶线结果

Definium Therapeutics宣布在DT120 Odt针对重度抑郁症的第二个三期关键研究“Ascend”中完成首例患者给药

异动解读 | 特朗普签署迷幻药监管支持行政命令，Definium Therapeutics盘前大涨6.34%

异动解读 | 特朗普签署迷幻药监管支持行政命令，Definium Therapeutics夜盘大涨5.65%

BUZZ--美国股票走势-TopBuild, MDA Space, Biogen

Definium Therapeutics飙升14.5%，COMPASS Pathways暴涨21.5%，GH Research跃升18.9%，Enveric Biosciences上涨6.6%，Cybin美国上市股票劲扬15.5%

BUZZ-特朗普发出监管支持信号后，迷幻药开发商崛起

Definium Therapeutics 研发DT120口腔崩解片针对广泛性焦虑症、重度抑郁症及其他严重脑健康疾病

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/DFTX/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":34.44,"timestamp":1791912651022,"preClose":35.2,"halted":0,"volume":730163,"delay":0,"changeRate":-0.021590909090909233,"floatShares":129971489,"shares":134366950,"eps":-3.482311,"marketStatus":"交易中","change":-0.76,"latestTime":"10-13 13:30:51 EDT","open":34.83,"high":34.95,"low":34.03,"amount":25299070.959575,"amplitude":0.026136,"askPrice":34.48,"askSize":120,"bidPrice":34.42,"bidSize":160,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":35.2,"preHourTrading":{"tag":"盘前","latestPrice":34.79,"preClose":35.2,"latestTime":"09:29 EDT","volume":3323,"amount":117173.485988,"timestamp":1791898199999,"change":-0.41,"changeRate":-0.011648,"amplitude":0.03033},"postHourTrading":{"tag":"盘后","latestPrice":35.37,"preClose":35.2,"latestTime":"19:30 EDT","volume":15544,"amount":547087.5145,"timestamp":1791847803321,"change":0.17,"changeRate":0.00483,"amplitude":0.01108},"volumeRatio":0.525814,"impliedVol":0.5153,"impliedVolPercentile":0.0054},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":129971489,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":0.525814,"shares":134366950,"dividePrice":0,"high":34.95,"amplitude":0.026136,"preClose":35.2,"low":34.03,"week52Low":10.4646,"pbRate":"5.04","week52High":49.7,"institutionHeld":0,"latestPrice":34.44,"committee":0.142857,"eps":-3.482311,"divideRate":0,"volume":730163,"delay":0,"ttmEps":-3.482311,"open":34.83,"prevYearClose":13.39,"prevWeekClose":36.9,"prevMonthClose":38.06,"prevQuarterClose":38.06,"fiveDayClose":35.62,"twentyDayClose":36.82,"sixtyDayClose":42.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"盘后","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"盘后","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787198400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-10-12","current":-9.889984,"percent":0.375,"low":-27.074722,"twenty":-17.026359,"median":-11.77112,"eighty":-9.952097,"high":-8.802064,"avg":-13.971462,"sd":5.091426,"marketCap":4958140455},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-11","current":-14.329791,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"marketCap":5069665023},{"date":"2026-09-18","current":-14.690599,"twenty":-17.210941,"median":-11.23988,"eighty":-9.921368,"marketCap":5197313626},{"date":"2026-09-25","current":-13.949992,"twenty":-17.164605,"median":-11.372203,"eighty":-9.935823,"marketCap":4935298073},{"date":"2026-10-02","current":-14.280417,"twenty":-17.093203,"median":-11.537867,"eighty":-9.941944,"marketCap":5052197320},{"date":"2026-10-09","current":-12.981507,"twenty":-17.033955,"median":-11.725012,"eighty":-9.950275,"marketCap":4592662351},{"date":"2026-10-12","current":-14.014558,"twenty":-17.026359,"median":-11.77112,"eighty":-9.952097,"marketCap":4958140455}],"updateTime":1791912651837},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2645389070","title":"BUZZ-Definium Therapeutics宣布5亿美元股权融资后股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2645389070","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645389070?lang=zh_cn&edition=fundamental","pubTime":"2026-06-23 04:29","pubTimestamp":1782160182,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4S42U1LG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382058.USD","LU1244550221.USD","LU2211815571.USD","LU1119994496.HKD","BK4566","JPX","LU2023250504.SGD","IE00B1XK9C88.USD","LU1917777945.USD","LU0971096721.USD","IE000M9KFDE8.USD","LU2746668461.USD","LU2237443978.SGD","LU0256863811.USD","LU2237443382.USD","IE0034235295.USD","LU2244417387.USD","LU0211327993.USD","IE00BKDWB100.SGD","JPMO","LU0345770993.USD","LU1914381329.SGD","LU1496350502.SGD","BK4550","LU0683600562.USD","DFTX","IE00BJTD4N35.SGD","LU1629891620.HKD","LU1974910355.USD","LU0106831901.USD","LU1244550577.SGD","IE00BHPRN162.USD","LU1032466523.USD","LU2106854487.HKD","LU0187121727.USD","LU0251132253.USD","JPO","LU1366192091.USD","LU0208291251.USD","LU1670627923.USD","LU2242649171.HKD","LU2357627491.SGD","IE00BDRTCR15.USD","IE00BZ1G4Q59.USD","IE00BWXC8680.SGD","LU1894683348.USD","LU2505996681.GBP","LU0820562030.AUD","IE00BLSP4452.SGD","LU2023250330.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645024879","title":"BUZZ——美国股市动态-维斯通、英赛特、阿波吉","url":"https://stock-news.laohu8.com/highlight/detail?id=2645024879","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645024879?lang=zh_cn&edition=fundamental","pubTime":"2026-06-22 19:54","pubTimestamp":1782129281,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4S42U0X9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564495.EUR","LU0466842654.USD","RGNX","BK4574","TSYY","BK4563","LU0053671581.USD","LU1674673428.USD","BK4527","LU0345769128.USD","BK4124","LU2403377893.USD","HOOY","BK4555","07766","LU0082616367.USD","LU1861215975.USD","SG9999015986.USD","TESL","LU2087621335.USD","TSII","LU1629891620.HKD","BK4532","LU2108987350.USD","LU1366192091.USD","HOOX","LU2756315664.SGD","IE00BWXC8680.SGD","LU1861220033.SGD","LU2063271972.USD","LU0820561818.USD","BK4547","BK4581","LU1720051017.SGD","TSDD","LU0109391861.USD","CRSH","IE00BSNM7G36.USD","IE00BK4W5M84.HKD","BK4099","LU0198837287.USD","LU2168563687.JPY","APGE","LU1839511570.USD","SG9999015952.SGD","TEST","LU0348723411.USD","BK4585","IE00B1XK9C88.USD","LU0210536198.USD","TLA","TSLG","LU1778281490.HKD","LU0823414478.USD","BK4505","BK4213","LU2326559502.SGD","LU2750360997.AUD","BK4551","IE00BJLML261.HKD","BK4007","IE00B19Z9505.USD","BK4604","LU2168564065.EUR","BK4534","TSLP","DFTX","BK4539","BK4598","LU0077335932.USD","LU0964807845.USD","BK4592","LU2462157665.USD","LU0097036916.USD","IE00B19Z8X17.USD","TSLQ","LU0823411888.USD","LU1551013342.USD","TSLT","HOOI","BK4548","LU0345769631.USD","LU2236285917.USD","LU2357305700.SGD","HOOD","BK4127","LU2750360641.GBP","SG9999015978.USD","TSLL","09366","LU2756315318.SGD","LU2471134952.CNY","LU2168564149.EUR","TSLA","LU0757428866.USD","LU0719512351.SGD","HOII","BK4139","LU2360106780.USD","LU2602419157.SGD","HK0000914660.USD","TSL","TSLI","LU1861559042.SGD","HK0000914686.HKD","LU0820561909.HKD","LU1815336091.USD","TSLO","LU0345770993.USD","LU2360107168.USD","IE00B19Z8W00.USD","LU2250418816.HKD","LU1066051811.HKD","BK4511","LU2290526834.HKD","LU1551013425.SGD","LU1914381329.SGD","HOOW","LU1720051108.HKD","LU2168564222.USD","LU2471134796.USD","LU1066051225.USD","07366","LU0056508442.USD","BK4533","LU0316494557.USD","LU0943347566.SGD","IE00BZ199S13.USD","BK4543","LU2456880835.USD","TSLS","LU1232071149.USD","LU2249611893.SGD","HOOZ","LU0320765059.SGD","BK4516","LU0053666078.USD","LU2896262040.SGD","ROBN","IE00B1BXHZ80.USD","LU1674673691.USD","LU1852331112.SGD","VC","LU1548497426.USD","IE00BK4W5L77.USD","LU0820562030.AUD","HOYY","BK4588","LU2023250330.USD","LU0345770308.USD","LU2420271590.USD","HODU","TSLZ","LU0689472784.USD","LU1861558580.USD","GPRK","LU0133085943.USD","LU1429558221.USD","LU2471134523.USD","BK4612","SG9999015945.SGD","LU0323591593.USD","LU2417539215.USD","LU0708995401.HKD","LU1066051498.USD","LU1435385759.SGD","LU0672654240.SGD","LU1267930730.SGD","09766","LU2213496289.HKD","BK4550","LU2471134879.HKD","TSLW","HOOG","LU1066053197.SGD","INCY","TSLY","IE0034235303.USD","LU0234570918.USD","LU1145028129.USD","TSLR","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645033029","title":"BUZZ-Definium Therapeutics股价大涨，因其抗抑郁药物晚期临床试验数据表现良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2645033029","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645033029?lang=zh_cn&edition=fundamental","pubTime":"2026-06-22 19:13","pubTimestamp":1782126817,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4S42U0TI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169167287","title":"Definium Therapeutics股价盘前飙升18.5%，其基于LSD的抑郁药物在后期试验中显效","url":"https://stock-news.laohu8.com/highlight/detail?id=1169167287","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169167287?lang=zh_cn&edition=fundamental","pubTime":"2026-06-22 19:09","pubTimestamp":1782126566,"startTime":"0","endTime":"0","summary":"Definium Therapeutics的股价在盘前交易时段大幅上涨18.5%，这一显著波动源于公司公布了一项关键后期临床试验的积极结果。试验数据显示，该公司研发的一款基于LSD的口服药物，在减轻重度抑郁症症状方面展现出了显著疗效。这项突破性的研究成果为抑郁症治疗领域带来了新的希望，同时也极大地提振了市场对Definium Therapeutics未来前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029980","title":"Definium公司基于LSD的药片在晚期临床试验中减轻了抑郁症状","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029980","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029980?lang=zh_cn&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126036,"startTime":"0","endTime":"0","summary":"路透6月22日 - Definium Therapeutics公司周一表示，在一项晚期临床试验中，其基于LSD的试验性药片单次给药显著减轻了患者的重度抑郁症状。Definium公司的药物总体耐受性良好，99%的不良事件为轻度至中度，主要发生在给药当天，且未观察到严重的安全问题或自杀念头增加的情况。该公司表示，这些结果使其更接近向美国食品药品监督管理局提交申请，目前正在开展第二项抑郁症晚期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4S42U0R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109486940","title":"Definium Therapeutics公布DT120口崩片治疗重度抑郁症的3期EMERGE研究积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1109486940","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109486940?lang=zh_cn&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126018,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，其针对重度抑郁症（MDD）的候选药物DT120口崩片（ODT）在关键的3期EMERGE研究中取得了积极的顶线结果。该研究达到了其主要终点，显示出与安慰剂相比，在改善抑郁症状方面具有统计学显著性和临床意义的优势。安全性特征与先前研究一致，未发现新的安全问题。这一积极数据为DT120的后续监管申请奠定了坚实基础，标志着公司在精神疾病治疗领域的重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147229029","title":"Definium Therapeutics：DT120口崩片研究达成主要及所有关键次要疗效终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1147229029","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147229029?lang=zh_cn&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126016,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，其候选药物DT120口崩片的一项临床研究，已成功达成预设的主要疗效终点以及所有关键性的次要疗效终点。这一积极结果标志着该药物在目标适应症的开发中取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138440350","title":"Definium Therapeutics 公布 DT120 ODT 临床数据：总体耐受性良好，未出现严重不良事件或自杀倾向信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1138440350","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138440350?lang=zh_cn&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126014,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) 近日公布了其候选药物 DT120 口腔崩解片（ODT）的临床研究结果。数据显示，该药物在试验中总体耐受性良好，未观察到任何严重不良事件，也未发现与自杀倾向相关的信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194348262","title":"Definium Therapeutics将于2026年6月22日讨论重度抑郁症III期EMERGE研究的顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1194348262","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194348262?lang=zh_cn&edition=fundamental","pubTime":"2026-06-22 05:01","pubTimestamp":1782075697,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，将于2026年6月22日就其针对重度抑郁症的III期EMERGE研究的顶线结果进行讨论。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137501338","title":"Definium Therapeutics宣布在DT120 Odt针对重度抑郁症的第二个三期关键研究“Ascend”中完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1137501338","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137501338?lang=zh_cn&edition=fundamental","pubTime":"2026-05-12 19:01","pubTimestamp":1778583709,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，在其针对重度抑郁症的候选药物DT120 Odt的第二个关键性三期临床试验“Ascend”中，已完成对首例患者的给药。这标志着该药物临床开发项目的一个重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142902855","title":"异动解读 | 特朗普签署迷幻药监管支持行政命令，Definium Therapeutics盘前大涨6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142902855","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142902855?lang=zh_cn&edition=fundamental","pubTime":"2026-04-21 17:11","pubTimestamp":1776762674,"startTime":"0","endTime":"0","summary":"Definium Therapeutics（股票代码：DFTX）今日盘前股价大幅上涨6.34%，引起了市场的广泛关注。消息面上，此次股价异动主要源于行业性的政策利好。据报道，美国总统特朗普签署了一项行政命令，要求卫生监管机构加快对伊博格碱等迷幻药的审查流程，并拨出5000万美元专款用于相关研究。此举被市场解读为政府对迷幻药治疗领域的正式认可与实质性支持，从而提振了投资者信心。受此消息影响，整个迷幻药开发板块应声上涨。分析人士指出，该行政命令标志着官方支持从“空谈”转向“真实可操作”，获得“突破性疗法”称号的迷幻药未来有望获得优先审查，从而大幅缩短审批时间，为相关公司带来发展机遇。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127343471","title":"异动解读 | 特朗普签署迷幻药监管支持行政命令，Definium Therapeutics夜盘大涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127343471","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127343471?lang=zh_cn&edition=fundamental","pubTime":"2026-04-21 10:06","pubTimestamp":1776737206,"startTime":"0","endTime":"0","summary":"迷幻药开发商Definium Therapeutics今日夜盘股价大幅上涨5.65%，表现亮眼。消息面上，此次股价异动主要源于行业性的政策利好。据报道，美国总统特朗普于周六签署了一项行政命令，要求卫生监管机构加快对伊博格碱等迷幻药的审查流程，并拨出5000万美元专款用于相关研究。此举被市场解读为政府对迷幻药治疗领域的正式认可与实质性支持。受此消息提振，整个迷幻药开发板块应声上涨。除Definium Therapeutics外，Atai Beckley、Compass Pathways、Enveric Biosciences等多家同业公司股价均录得显著涨幅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628725578","title":"BUZZ--美国股票走势-TopBuild, MDA Space, Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2628725578","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628725578?lang=zh_cn&edition=fundamental","pubTime":"2026-04-20 21:06","pubTimestamp":1776690369,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nL4T4130WA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","AAL","ASTS","DFTX","GHRS","AMZN","ASTN","MRVL","SCCO","BIIB","OKTA","FRMI","CLDX","DVN","OXY","RIO.AU","SRFM","AMZP","CLF","AZYY","GTLB","HL","RBC","NKTR","SF","META","RIO.UK","JEF","XOM","CCL.UK","JPMO","GLSI","CCL","LION","HLXX","CVX","PASG","USAR","ATAI","NEM","BMI","WHR","BLD","FCX","SOC","CDE","AMZD","QXO","AU","BHP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161481278","title":"Definium Therapeutics飙升14.5%，COMPASS Pathways暴涨21.5%，GH Research跃升18.9%，Enveric Biosciences上涨6.6%，Cybin美国上市股票劲扬15.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161481278","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161481278?lang=zh_cn&edition=fundamental","pubTime":"2026-04-20 18:40","pubTimestamp":1776681631,"startTime":"0","endTime":"0","summary":"生物科技板块今日表现亮眼，多只精神健康领域个股出现大幅上涨。Definium Therapeutics股价强势攀升14.5%，COMPASS Pathways更实现21.5%的惊人涨幅。GH Research同期录得18.9%的可观增长，Enveric Biosciences也上涨6.6%。值得关注的是，Cybin公司的美国上市股票同样表现强劲，单日涨幅达到15.5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DFTX","ENVB","GHRS","CMPS","BK4539","BK4007","ATAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628454697","title":"BUZZ-特朗普发出监管支持信号后，迷幻药开发商崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2628454697","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628454697?lang=zh_cn&edition=fundamental","pubTime":"2026-04-20 17:16","pubTimestamp":1776676608,"startTime":"0","endTime":"0","summary":"4月20日 - ** 美国总统特朗普周六签署了一项行政命令 ，要求卫生监管机构加快对伊博格堿等迷幻药的审查，并拨出5000万美元用于研究，此后迷幻药开发商的股价在盘前上涨。** 杰富瑞指出，获得 \"突破性疗法 \"称号的迷幻药可能会获得 \"局长国家优先审查券\"，从而将食品及药物管理局的审查时间从 6-10 个月缩短到 1-2 个月。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nL4T4130IH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ATAI","ENVB","GHRS","CMPS","DFTX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180337716","title":"Definium Therapeutics 研发DT120口腔崩解片 针对广泛性焦虑症、重度抑郁症及其他严重脑健康疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1180337716","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180337716?lang=zh_cn&edition=fundamental","pubTime":"2026-04-19 07:43","pubTimestamp":1776555796,"startTime":"0","endTime":"0","summary":"Definium Therapeutics公司正在积极推进其核心产品DT120口腔崩解片的研发进程，该药物主要瞄准广泛性焦虑症、重度抑郁症以及其他一系列严重的脑健康疾病的治疗领域。\n这款名为DT120 ODT的创新疗法，展现了公司在精神健康与神经系统疾病治疗方面的前沿探索。其研发策略聚焦于解决当前临床未满足的重大需求，旨在为深受相关疾病困扰的患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":56,"code":"91000000","status":"200"}]}}